Decreased expression of claudin-1 in rectal cancer: A factor for recurrence and poor prognosis

Anticancer Research

Volumn 31, Issue 7, 2011, Pages 2517-2526

  Yoshida, Takefumi ^a   Kinugasa, Tetsushi ^a   Akagi, Yoshito ^a   Kawahara, Akihiko ^a   Romeo, Kansakar ^a   Shiratsuchi, Ichitarou ^a   Ryu, Yasuhiko ^a   Gotanda, Yukito ^a   Shirouzu, Kazuo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Claudin 1; Prognostic factor; Rectal cancer; Recurrence

Indexed keywords

CLAUDIN 1;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PERINEURIUM; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECTUM CANCER; RECURRENT CANCER; STAINING; TISSUE SECTION; TUMOR CELL; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CELL DIFFERENTIATION; CELL MEMBRANE; CYTOPLASM; DOWN-REGULATION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; RECURRENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 79961195718     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Furuse M, Fujita K, Hiiragi T, Fujimoto K and Tsukita S: Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141: 1539-1550, 1998. (Pubitemid 28309169)
2. Tsukita S and Furuse M: Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 149: 13-16, 2000. (Pubitemid 30196694)
3. Itoh M, Furuse M, Morita K, Kubota K, Saitou M and Tsukita S: Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 147: 1351-1363, 1999. (Pubitemid 30012818)
4. Soini Y: Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology 46: 551-560, 2005.
5. Ue JW, Ue SJ, Seo J, Song SY, Ahn G, Park CS, Lee JH, Kim BG and Bae DS: Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol Oncol 97: 53-59, 2005. (Pubitemid 40403674)
6. Cheung ST, Leung KL, Ip YC, Chen X, Fong DY, Ng IO, Fan ST and So S: Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. Clin Cancer Res 11: 551-556, 2005. (Pubitemid 40116879)
7. Ueda J, Semba S, Chiba H, Sawada N, Seo Y, Kasuga M and Yokozaki H: Heterogeneous expression of claudin-4 in human colorectal cancer: decreased claudin-4 expression at the invasive front correlates cancer invasion and metastasis. Pathobiology 74: 32-41, 2007. (Pubitemid 46745168)
8. Matsuda Y, Semba S, Ueda J, Fuku T, Hasuo T, Chiba H, Sawada N, Kuroda Y and Yokozaki H: Gastric and intestinal claudin expression at the invasive front of gastric carcinoma. Cancer Sci 95: 1014-1019, 2007. (Pubitemid 46865385)
9. Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Lohr M et al: Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 63: 6265-6271, 2003.
10. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP and Sukumar S: Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22: 2021-2033, 2003. (Pubitemid 36523639)
11. Tokes AM, Kulka J, Paku S, Szik A, Paska C, Novak PK, Szilak L, Kiss A, Bogi K and Schaff Z: Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7: R296-305, 2005.
12. Nichols LS, Ashfaq R and Iacobuzio-Donahue CA: Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am J Clin Pathol 121: 226-230, 2004. (Pubitemid 38140127)
13. Gonzalez-Mariscal L, Betanzos A, Nava P and Jaramillo BE: Tight junction proteins. Prog Biophys Mol Biol 81: 1-44, 2003. (Pubitemid 35436609)
14. Kinugasa T, Huo Q, Higashi D, Shibaguchi H, Kuroki M, Tanaka T, Futami K, Yamashita Y, Hachimine K, Maekawa S et al: Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer. Anticancer Res 27: 3729-3734, 2007. (Pubitemid 47598437)
15. Huo Q, Kinugasa T, Wang L, Huang J, Zhao J, Shibaguchi H, Kuroki M, Tanaka T, Yamashita Y, Nabeshima K et al: Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer. Anticancer Res 29: 851-857, 2009.
16. Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM and Mullin JM: Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 20: 1425-1431, 1999.
17. Mullin JM: Epithelial barriers, compartmentation, and cancer. Sci STKE 2004: pe2, 2004.
18. Martin TA and Jiang WG: Tight junctions and their role in cancer metastasis. Histol Histopathol 16: 1183-1195, 2001. (Pubitemid 32994462)
19. Hirohashi S and Kanai Y: Cell adhesion system and human cancer morphogenesis. Cancer Sci 94: 575-581, 2003. (Pubitemid 36975010)
20. Miwa N, Furuse M, Tsukita S, Niikawa N, Nakamura Y and Furukawa Y: Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent up-regulation in human colorectal cancers. Oncol Res 12: 469-476, 2001. (Pubitemid 33791807)
21. Hamazaki Y, Itoh M, Sasaki H, Furuse M and Tsukita S: Multi-PDZ domain protein 1 (MUPP1) is concentrated at tight junctions through its possible interaction with claudin-1 and junctional adhesion molecule. J Biol Chem 277: 455-461, 2002. (Pubitemid 34952079)
22. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Neff J, Washington MK and Beauchamp RD: Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 115: 1765-1776, 2005. (Pubitemid 40979715)
23. Resnick MB, Konkin T, Routhier J, Sabo E and Pricolo VE: Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 18: 511-518, 2005. (Pubitemid 40478114)
24. General Rules for Clinical and Pathological Studies on Cancer of Colon, Rectum and Anus, 7th edn (revised ver.). Tokyo, Japan: Kanehara Shuppan, 2009.
25. Kinugasa T, Sakaguchi T, Gu X and Reinecker HC: Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 118: 1001-1011, 2000. (Pubitemid 30346975)
26. Mees ST, Mennigen R, Spieker T, Rijcken E, Senninger N, Haier J and Bruewer M: Expression of tight and adherens junction proteins in ulcerative colitis associated colorectal carcinoma: upregulation of claudin-1, claudin-3, claudin-4, and beta-catenin. Int J Colorectal Dis 24: 361-368, 2009.
27. Song Y, Oda Y, Hori M, Kuroiwa K, Ono M, Hosoi F, Basaki Y, Tokunaga S, Kuwano M, Naito S et al: N-Myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin. Hum Pathol 41: 214-222, 2010.
28. Compton CC: Pathology report in colon cancer: What is prognostically important? Dig Dis 17: 67-79, 1999.
29. Eschrich S, Yang I, Bloom G, Kwong KY, Boulware D, Cantor A, Coppola D, Kruhoffer M, Aaltonen L, Orntoft TF et al: Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 23: 3526-3535, 2005.
30. Ghadimi BM, Grade M, Difilippantonio MJ, Varma S, Simon R, Montagna C, Fuzesi L, Langer C, Becker H, Liersch T et al: Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 23: 1826-1838, 2005.
31. Kim IJ, Lim SB, Kang HC, Chang HJ, Ahn SA, Park HW, Jang SG, Park JH, Kim DY, Jung KH et al: Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer. Dis Colon Rectum 50: 1342-1353, 2007. (Pubitemid 47472394)
32. Dos Reis PP, Bharadwaj RR, Machado J, Macmillan C, Pintilie M, Sukhai MA, Perez-Ordonez B, Gullane P, Irish J and Kamel-Reid S: Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma. Cancer 113: 3169-3180, 2008.
33. Ozaki H, Hiraoka T, Mizumoto R, Matsuno S, Matsumoto Y, Nakayama T, Tsunoda T, Suzuki T, Monden M, Saitoh Y et al: The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today 29: 16-22, 1999. (Pubitemid 29058554)
34. Law WL and Chu KW: Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg 240: 260-268, 2004. (Pubitemid 38963017)
35. Beard CJ, Chen MH, Cote K, Loffredo M, Renshaw AA, Hurwitz M and D'Amico AV: Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer. Int J Radiat Oncol Biol Phys 58: 19-24, 2004. (Pubitemid 38010332)
36. Duraker N, Sisman S and Can G: The significance of perineural invasion as a prognostic factor in patients with gastric carcinoma. Surg Today 33: 95-100, 2003. (Pubitemid 36269376)
37. Su CH, Tsay SH, Wu CC, Shyr YM, King KL, Lee CH, Lui WY, Liu TJ and P'Eng FK: Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 223: 384-394, 1996.
38. Shirouzu K, Isomoto H and Kakegawa T: Prognostic evaluation of perineural invasion in rectal cancer. Am J Surg 165: 233-237, 1993. (Pubitemid 23281373)